Seattle Genetics, Inc. (SGEN)
$9.30
-0.04 (-0.43%)
| CAPS Rating |
|
|---|---|
| Open | $9.26 |
| Previous Close | $9.34 |
| Daily Range | $9.13 - $9.47 |
| 52-Week Range | $7.00 - $14.94 |
| Market Cap | $934.95M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 323,938 |
| Average Daily Volume | 662,000 |
SGEN
VS S&P 500 (SPY)
How do you think SGEN will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
SGEN Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
SGEN News and Commentary
- CNBC on Seattle Genetics, Inc. – Ockham-RazorWire
- Fearful Stocks for Greedy Investors – The Motley Fool
- 3 Stocks in a Tailspin – The Motley Fool
- UPDATE 1-Seattle Genetics stops mid-stage cancer trial – Reuters
- A Plasma-tastic IPO – The Motley Fool
- Potential Can't Buy Me Love – The Motley Fool
- I Can't Believe My Company Got Acquired – The Motley Fool
- Illuminating Stock Option Problems – The Motley Fool
- A Secondary Offering? In This Market? – The Motley Fool
- World's Scariest Stock: Dendreon – The Motley Fool
- Biotech Investors' Dream Stocks – The Motley Fool
- Results IMPACT Volatility at Dendreon – The Motley Fool
- 3 Drugmakers With Multiple Shots on Goal – The Motley Fool
- Will Biopharma Acquisitions Never Cease? – The Motley Fool
- Seattle Genetics Has What Others Want – The Motley Fool
- May Summary – Blog at The Motley Fool
- Seattle Genetics Bulks Up Its Pipeline – The Motley Fool
- Seattle Genetics' Good Timing – The Motley Fool
- The Value of Myriad's Genes – The Motley Fool
- Quick Take: Scoping Out the Investing Sluggers – The Motley Fool
RSS Headlines
Fool UK
